Follow
Eivind Hovig
Eivind Hovig
Professor.1. Centre for bioinformatics. Dept. of Informatics, Univ of Oslo. 2. Oslo Univ. Hosp.
Verified email at ifi.uio.no
Title
Cited by
Cited by
Year
Database of p53 gene somatic mutations in human tumors and cell lines.
M Hollstein, K Rice, MS Greenblatt, T Soussi, R Fuchs, T Sørlie, E Hovig, ...
Nucleic acids research 22 (17), 3551, 1994
13651994
A literature network of human genes for high-throughput analysis of gene expression
TK Jenssen, A Lægreid, J Komorowski, E Hovig
Nature genetics 28 (1), 21-28, 2001
11332001
Ten simple rules for reproducible computational research
GK Sandve, A Nekrutenko, J Taylor, E Hovig
PLoS computational biology 9 (10), e1003285, 2013
8542013
Somatic Point Mutations in the p53 Gene of Human Tumors and Cell Lines: Updated Compilation
M Hollstein, B Shomer, M Greenblatt, T Soussi, E Hovig, R Montesano, ...
Nucleic acids research 24 (1), 141-146, 1996
6971996
Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database
P Møller, TT Seppälä, I Bernstein, E Holinski-Feder, P Sala, DG Evans, ...
Gut 67 (7), 1306-1316, 2018
5892018
Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database
P Møller, T Seppälä, I Bernstein, E Holinski-Feder, P Sala, DG Evans, ...
Gut 66 (3), 464-472, 2017
5822017
A uniform system for the annotation of vertebrate microRNA genes and the evolution of the human microRNAome
B Fromm, T Billipp, LE Peck, M Johansen, JE Tarver, BL King, ...
Annual review of genetics 49 (1), 213-242, 2015
5762015
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
M Dominguez-Valentin, JR Sampson, TT Seppälä, SW Ten Broeke, ...
Genetics in Medicine 22 (1), 15-25, 2020
5742020
Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects
P Hainaut, T Soussi, B Shomer, M Hollstein, M Greenblatt, E Hovig, ...
Nucleic acids research 25 (1), 151-157, 1997
3981997
Methods that remove batch effects while retaining group differences may lead to exaggerated confidence in downstream analyses
V Nygaard, EA Rødland, E Hovig
Biostatistics 17 (1), 29-39, 2016
3542016
A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing
TS Alioto, I Buchhalter, S Derdak, B Hutter, MD Eldridge, E Hovig, ...
Nature communications 6 (1), 1-13, 2015
3342015
Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma
GM Maelandsmo, VA Flørenes, T Mellingsaeter, E Hovig, RS Kerbel, ...
International journal of cancer 74 (4), 464-469, 1997
2501997
Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations.
AL Børresen, E Hovig, B Smith-Sørensen, D Malkin, S Lystad, ...
Proceedings of the National Academy of Sciences 88 (19), 8405-8409, 1991
2481991
Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase‐polymerase chain reaction assays used to detect micrometastatic tumor cells
P Ruud, Ø Fodstad, E Hovig
International journal of cancer 80 (1), 119-125, 1999
2461999
Screening for Germ Line TP53 Mutations in Breast Cancer Patients
AL Børresen, TI Andersen, J Garber, N Barbier-Piraux, S Thorlacius, ...
Cancer research 52 (11), 3234-3236, 1992
2431992
MirGeneDB 2.0: the metazoan microRNA complement
B Fromm, D Domanska, E Høye, V Ovchinnikov, W Kang, ...
Nucleic Acids Research 48 (D1), D132-D141, 2020
2412020
S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti …
K Bjørnland, JO Winberg, OT Ødegaard, E Hovig, T Loennechen, ...
Cancer research 59 (18), 4702-4708, 1999
2241999
Performance comparison of four exome capture systems for deep sequencing
CSR Chilamakuri, S Lorenz, MA Madoui, D Vodák, J Sun, E Hovig, ...
BMC genomics 15, 1-14, 2014
2132014
TP53 mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the zinc‐binding domains
AL Børresen, TI Andersen, JE Eyfjörd, RS Cornelis, S Thorlacius, Å Borg, ...
Genes, Chromosomes and Cancer 14 (1), 71-75, 1995
2111995
A sequence-oriented comparison of gene expression measurements across different hybridization-based technologies
WP Kuo, F Liu, J Trimarchi, C Punzo, M Lombardi, J Sarang, ME Whipple, ...
Nature biotechnology 24 (7), 832-840, 2006
1912006
The system can't perform the operation now. Try again later.
Articles 1–20